Inventor · disambiguated record
Deb K. Chatterjee
Also filed as: CHATTERJEE DEB · CHATTERJEE DEB K
47 granted patents·23 pending applications·1,538 citations·filing 1989–2023
99Inventor score
Files withINVITROGEN CORP20LIFE TECHNOLOGIES INC18LIFE TECHNOLOGIES CORP11CHATTERJEE DEB K4US HEALTH4
Top patents by PatentIndex Score
70 records- 0198US5047342ACloning and expression of T5 DNA polymeraseLIFE TECHNOLOGIES INC·Filed 1989·Granted Sep 10, 1991·188 cites·20 claims
- 0297US5912155ACloned DNA polymerases from Thermotoga neapolitanaLIFE TECHNOLOGIES INC·Filed 1995·Granted Jun 15, 1999·117 cites·47 claims
- 0395US5939301ACloned DNA polymerases from Thermotoga neapolitana and mutants thereofLIFE TECHNOLOGIES INC·Filed 1995·Granted Aug 17, 1999·92 cites·38 claims
- 0494US10040830B2Methods and compositions for protein deliveryUS HEALTH·Filed 2016·Granted Aug 7, 2018·18 cites·20 claims
- 0594US6506560B1Cloned DNA polymerases from Thermotoga and mutants thereofINVITROGEN CORP·Filed 1999·Granted Jan 14, 2003·64 cites·17 claims
- 0693US6830902B1Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesisINVITROGEN CORP·Filed 2000·Granted Dec 14, 2004·42 cites·2 claims
- 0793US6015668ACloned DNA polymerases from thermotoga and mutants thereofLIFE TECHNOLOGIES INC·Filed 1996·Granted Jan 18, 2000·70 cites·55 claims
- 0892US11718861B2Cancer immunotherapy by delivering class II MHC antigens using a VLP-repliconTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2020·Granted Aug 8, 2023·2 cites·10 claims
- 0992US10538743B2Delivery of packaged RNA to mammalian cellsUS HEALTH·Filed 2016·Granted Jan 21, 2020·6 cites·7 claims
- 1092US8043816B2Compositions and methods for temperature-dependent nucleic acid synthesisLIFE TECHNOLOGIES CORP·Filed 2009·Granted Oct 25, 2011·7 cites·15 claims
- 1192US7265206B2Methods of production of proteinsINVITROGEN CORP·Filed 2006·Granted Sep 4, 2007·10 cites·41 claims
- 1292US5948614ACloned DNA polymerases from thermotoga maritima and mutants thereofLIFE TECHNOLOGIES INC·Filed 1996·Granted Sep 7, 1999·116 cites·185 claims
- 1392US5270179ACloning and expression of T5 DNA polymerase reduced in 3'- to-5' exonuclease activityLIFE TECHNOLOGIES INC·Filed 1992·Granted Dec 14, 1993·176 cites·29 claims
- 1491US10577397B2Methods and compositions for protein deliveryTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2018·Granted Mar 3, 2020·10 cites·18 claims
- 1591US7259242B2Methods for production of proteinsINVITROGEN CORP·Filed 2006·Granted Aug 21, 2007·9 cites·33 claims
- 1688US7223566B2Methods for production of proteinsINVITROGEN CORP·Filed 2003·Granted May 29, 2007·10 cites·22 claims
- 1786US9296790B2Methods and compositions for protein deliveryCHATTERJEE DEB·Filed 2009·Granted Mar 29, 2016·21 cites·19 claims
- 1886US6140086AMethods and compositions for cloning nucleic acid moleculesFiled 1998·Granted Oct 31, 2000·65 cites·27 claims
- 1985US9506041B2Delivery of packaged RNA to mammalian cellsUS HEALTH·Filed 2013·Granted Nov 29, 2016·3 cites·8 claims
- 2085US7501237B2Polymerases for analyzing or typing polymorphic nucleic acid fragments and uses thereofLIFE TECHNOLOGIES CORP·Filed 2001·Granted Mar 10, 2009·62 cites·42 claims
- 2185US6703484B2Methods for production of proteinsINVITROGEN CORP·Filed 1998·Granted Mar 9, 2004·30 cites·12 claims
- 2281US7115406B2Recombinant method for making RSV reverse transcriptases and mutants thereofINVITROGEN CORP·Filed 2002·Granted Oct 3, 2006·4 cites·62 claims
- 2381US5716819ACloning and expression of T5 DNA polymerase reduced in 3'-to-5' exonuclease activityLIFE TECHNOLOGIES INC·Filed 1996·Granted Feb 10, 1998·40 cites·21 claims
- 2479US12049639B2Cancer immunotherapy by delivering class II MHC antigens using a VLP-repliconTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2023·Granted Jul 30, 2024·0 cites·15 claims
- 2579US8012715B2Methods for production of proteinsLIFE TECHNOLOGIES CORP·Filed 2006·Granted Sep 6, 2011·1 cites·24 claims
- 2679US6518019B2Compositions and methods for reverse transcription of nucleic acid moleculesINVITROGEN CORP·Filed 1999·Granted Feb 11, 2003·26 cites·116 claims
- 2777US6835561B1Composition of reverse transcriptases and mutants thereofINVITROGEN CORP·Filed 1999·Granted Dec 28, 2004·22 cites·21 claims
- 2876US6444424B1Cloned DNA polymerases from Thermotoga neapolitanaINVITROGEN CORP·Filed 1999·Granted Sep 3, 2002·34 cites·31 claims
- 2976US2011008770A1Compositions and methods for reverse transcription of nucleic acid moleculesLIFE TECHNOLOGIES CORP·Filed 2009·Application pending·0 cites
- 3073US6306588B1Polymerases for analyzing or typing polymorphic nucleic acid fragments and uses thereofINVITROGEN CORP·Filed 1998·Granted Oct 23, 2001·30 cites·9 claims
- 3169US9409942B2Methods for production of proteinsLIFE TECHNOLOGIES CORP·Filed 2013·Granted Aug 9, 2016·0 cites·17 claims
- 3269USH1531HThermophilic DNA polymeraseFiled 1994·Granted May 7, 1996·32 cites·2 claims
- 3369US2009191560A1Mutant dna polymerases and uses therofLIFE TECHNOLOGIES CORP·Filed 2008·Application pending·0 cites
- 3469US2009155775A1Cloned dna polymerases from thermotoga and mutants thereofINVITROGEN CORP·Filed 2007·Application pending·0 cites
- 3568US6989259B2Recombinant methods for making reverse transcriptases and mutants thereofINVITROGEN CORP·Filed 1998·Granted Jan 24, 2006·14 cites·31 claims
- 3668US5082784ACloned kpni restriction-modification systemLIFE TECHNOLOGIES INC·Filed 1990·Granted Jan 21, 1992·32 cites·5 claims
- 3768US2020102545A1Delivery of packaged rna to mammalian cellsTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2019·Application pending·0 cites
- 3867US7736874B2Methods for cloning amplified nucleic acid moleculesLIFE TECHNOLOGIES CORP·Filed 2004·Granted Jun 15, 2010·0 cites·8 claims
- 3967US5334526ACloning and expression of AluI restriction endonucleaseLIFE TECHNOLOGIES INC·Filed 1993·Granted Aug 2, 1994·27 cites·22 claims
- 4067US2005089922A1Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesisFiled 2004·Application pending·0 cites
- 4166US2005112637A1Mutant DNA polymerases and uses thereofFiled 2004·Application pending·0 cites
- 4266US2007269878A1Compositions and methods for reverse transcription of nucleic acid moleculesINVITROGEN CORP·Filed 2007·Application pending·0 cites
- 4366US2008171388A1Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesisINVITROGEN CORP·Filed 2007·Application pending·0 cites
- 4465US5192675ACloned KpnI restriction-modification systemLIFE TECHNOLOGIES INC·Filed 1992·Granted Mar 9, 1993·27 cites·18 claims
- 4564US5312746ACloning and expressing restriction endonucleases and modification methylases from caryophanonLIFE TECHNOLOGIES INC·Filed 1993·Granted May 17, 1994·22 cites·44 claims
- 4664US5248605ACloning and expressing restriction endonucleases from haemophilusLIFE TECHNOLOGIES INC·Filed 1992·Granted Sep 28, 1993·22 cites·19 claims
- 4764US5231021ACloning and expressing restriction endonucleases and modification methylases from xanthomonasLIFE TECHNOLOGIES INC·Filed 1992·Granted Jul 27, 1993·19 cites·17 claims
- 4864US2016024494A1Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesisLIFE TECHNOLOGIES CORP·Filed 2015·Application pending·0 cites
- 4964US2016312242A1Cancer immunotherapy by delivering class ii mhc antigens using a vlp-repliconUS HEALTH·Filed 2014·Application pending·0 cites
- 5063US8389681B2Methods for production of proteinsCHATTERJEE DEB K·Filed 2006·Granted Mar 5, 2013·0 cites·42 claims
Showing the top 50 of 70 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Deb K. Chatterjee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →